Evidence map›Paper›PMID 29439406›Full record

ArticleInternational journal of molecular sciences2018

Site-Specific Cleavage by Topoisomerase 2: A Mark of the Core Centromere.

Walter E Mills, Jennifer M Spence, Tatsuo Fukagawa, Christine J Farr

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Walter E MillsDepartment of Genetics, University of Cambridge, Downing St, Cambridge CB2 3EH, UK. w_e_mills@yahoo.co.uk.
Jennifer M SpenceDepartment of Genetics, University of Cambridge, Downing St, Cambridge CB2 3EH, UK. jennyspence44@yahoo.co.uk.
Tatsuo FukagawaLaboratory of Chromosome Biology, Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan. tfukagawa@fbs.osaka-u.ac.jp.
Christine J FarrDepartment of Genetics, University of Cambridge, Downing St, Cambridge CB2 3EH, UK. c.farr@gen.cam.ac.uk.
University of Cambridge · GBOsaka University · JP

Funding

Biotechnology and Biological Sciences Research Council BBS/B/04994Wellcome Trust
6 · The paper itself

Abstract

In addition to its roles in transcription and replication, topoisomerase 2 (topo 2) is crucial in shaping mitotic chromosomes and in ensuring the orderly separation of sister chromatids. As well as its recruitment throughout the length of the mitotic chromosome, topo 2 accumulates at the primary constriction. Here, following cohesin release, the enzymatic activity of topo 2 acts to remove residual sister catenations. Intriguingly, topo 2 does not bind and cleave all sites in the genome equally; one preferred site of cleavage is within the core centromere. Discrete topo 2-centromeric cleavage sites have been identified in α-satellite DNA arrays of active human centromeres and in the centromere regions of some protozoans. In this study, we show that topo 2 cleavage sites are also a feature of the centromere in

Indexed as

AnimalsCell Cycle ProteinsCell LineCentromereCentromere Protein AChickensChromosomal Proteins, Non-HistoneCohesinsDNA, SatelliteDNA Topoisomerases, Type IIDrosophila melanogasterHumansSchizosaccharomycesCell Cycle ProteinsCentromere Protein AChromosomal Proteins, Non-HistoneCohesinsDNA, SatelliteDNA Topoisomerases, Type IIcentromerecleavageetoposidemitosissecondary DNA structuretopoisomerase 2α (topo 2α)

Identifiers

PMID29439406
PMCPMC5855756
OpenAlexW2790225607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.